| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |